Belimumab not checked

GSK

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 4 trial completes
Trials
9 active
13 in total · 11 in the EU
Targets
 

What this is

How it works
An antibody: a lab-made immune protein built to latch onto one target in the body.-mab: monoclonal antibodies WHO name stem
How it’s given
“Belimumab 200 mg/mL will be administered as SC injection in left or right thigh and the abdomen.”In the company’s words, NCT04179032 on ClinicalTrials.gov
Tested for
Systemic Lupus Erythematosus (2 trials), Lung Diseases, Interstitial, Connective Tissue Diseases, Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Main trialPhase 4
“This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ongoing disease activity despite stable first-line SLE therapy.”In the company’s words, NCT06411249 on ClinicalTrials.gov
Other names
BENLYSTA

Other drugs for Systemic Lupus Erythematosus

All 131 drugs for Systemic Lupus Erythematosus

Coming up4

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials13

TrialPhaseCompletesWhat it tests
Phase 4Active, not recruiting 29 Jun 2027 A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Phase 3Recruiting 30 Aug 2029 A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Phase 3Recruiting 27 Sep 2030 A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Phase 2/3Recruiting 30 Aug 2029 A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Phase 2Active, not recruiting 16 Jan 2023 Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
Phase 4Completed 18 Jun 2018 Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Phase 3Completed 25 Jul 2019 Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Phase 2/3Ended not given (Synbiose-2 )Synergetic B-cell immunomodulation in SLE – 2 nd study
Phase 2Authorised not given BE-MOBILYZED: BElimumab to MOBIlise memory B-cells from secondary LYmhoid organs to improve memory B-cell HLA-specificity profiling to support delisting for transplant access in highly-sensitiZED.
Phase 2Ended not given A phase II trial of belimumab in combination with rituximab/venetoclax in patients with refractory or relapsed chronic lymphocytic leukemia
Phase 3Authorised not given RITUX-PLUS 2 : A phase 3 randomized and double-blind controlled trial comparing the efficacy and safety of rituximab combined with subcutaneous belimumab versus rituximab + placebo in adult patients with persistent or chronic immune thrombocytopenia (ITP)
Phase 2Authorised not given TRIBECA - Multicenter randomized double-blind study comparing the efficacy and safety of belimumab in the treatment of non-infectious active cryoglobulinemia vasculitis compared to placebo TRIBECA STUDY (Treatment after RItuximab with BElimumab in mixed Cryoglobulinemia Associated vasculitis)
Phase 4Authorised not given The effects of belimumab on synovial inflammation and composition of lymph nodes in SLE patients
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Belimumab

Following is part of Solo: you see every change to Belimumab the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in